The Europe medical cannabis market is on a remarkable growth trajectory, projected to surge from US$ 492.1 million in 2021 to US$ 13,801.0 million by 2028, at a striking CAGR of 61.1% from 2022 to 2028. This exponential expansion is primarily fueled by intensified research into the therapeutic potential of cannabis and increasing government investment and policy support. However, persistent concerns regarding its illicit use as a recreational drug may pose challenges to broader market acceptance.
Across Europe, a growing number of countries are enacting medical cannabis legislation. Yet, official initiatives to educate healthcare professionals about cannabis-based treatments remain limited. A notable exception occurred in 2016, when Macedonia hosted a government-backed program in Skopje to train local healthcare providers, featuring international cannabis experts. This marked a pivotal moment in the country’s journey toward integrating cannabis into mainstream medical practice.
📚Download Full PDF Sample Copy of Market Report @
https://www.businessmarketinsights.com/sample/TIPRE00018766
Macedonia now stands at the forefront of opportunity, as its evolving healthcare system embraces modernization. Licensed local medical specialists are authorized to prescribe cannabis, and proactive collaboration between cannabis advocates and government bodies has led to the development of structured medical cannabis training for physicians. Public perception has shifted dramatically, with growing acceptance of cannabis as a legitimate medical solution.
The accelerating momentum of Macedonia’s medical cannabis movement underscores a broader call to action for the European Commission and EU Member States. To unlock the full potential of cannabis in healthcare, it is imperative to dismantle regulatory, financial, and cultural obstacles and actively support scientific research in this promising field.
Strategic Insights into the European Medical Cannabis Market
Strategic insights into the European medical cannabis market deliver a comprehensive, data-driven view of the evolving industry landscape. By examining emerging trends, leading market players, and regional dynamics, these insights provide stakeholders with the tools needed to uncover underserved segments and craft distinctive value propositions.
Through advanced data analytics, businesses—ranging from investors to manufacturers—can forecast market developments and adapt proactively to regulatory, consumer, and competitive shifts. This forward-looking approach is critical in a sector as dynamic and complex as medical cannabis in Europe.
Ultimately, strategic insights serve as a catalyst for informed decision-making, enabling stakeholders to enhance profitability, gain competitive advantages, and align with long-term market opportunities.
Market leaders and key company profiles
Organigram Holdings Inc
Aurora Cannabis Inc
Cannabis Science, Inc
Canopy Growth Corporation
Medical Marijuana Inc
VIVO Cannabis Inc
Tikun Olam
Tilray
The Cronos Group
Canvory
Europe Medical Cannabis Regional Insights
The geographic scope of the Europe Medical Cannabis refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
Similarly, the government is granting funds to accelerate R&D activities on cannabis use for COVID-19. For instance, in September 2020, EXMceuticals Inc. announced receiving funds for focusing on R&D for landmark COVID-19 activities. The European Union and the Portuguese government have allocated funds of ~US$ 353,000 (EUR 302,000) to support the company’s BioBlockCOVID project, which aims to create functional, natural, and innovative biocide formulations targeting specific molecules that makeup COVID-19. It is expected that the funds would enhance the research activities and help in innovating newer techniques. Thus, due to the above advancements, the medical cannabis market is expected to grow at a rapid pace during the forecast period.
Country Analysis: Germany – A Growing Hub for Medical Cannabis
Germany has emerged as a key player in the European medical cannabis landscape since legalizing the prescription of cannabis for medical use in March 2017. The German market offers a diverse range of medicinal cannabis products, with increasing accessibility through licensed pharmacies. This trend reflects a strong upward trajectory in patient demand and prescription rates.
According to Germany’s Federal Ministry of Health, the volume of medicinal cannabis sold to patients nearly doubled—rising from 33.8 kg in the first half of 2015 to 61.8 kg in the first half of 2016. This surge signals both growing acceptance among healthcare professionals and expanding treatment applications.
Germany has also been proactive in integrating clinical research into its medical cannabis policy framework. Clinical trials are increasingly exploring the efficacy of cannabis and single cannabinoids across a range of medical conditions. One notable example is Sativex, which was approved in 2011 as an add-on treatment for moderate-to-severe spasticity in multiple sclerosis (MS). Trials conducted in Germany have demonstrated that Sativex is not only effective but also cost-efficient in managing MS-related symptoms.
Further bolstering the market, the Federal Institute for Drugs and Medical Devices (BfArM) approved domestic cultivation of 10,400 kg of medical cannabis over a four-year period starting in July 2018. This initiative underscores the government’s commitment to reducing dependence on imports and ensuring stable supply for medical use.
Germany’s combination of regulatory support, growing patient base, and research-driven advancements makes it one of the most dynamic and promising markets for medical cannabis in Europe.
Can you see this our reports
Europe Halal Cosmetics Market – https://postyourarticle.com/europe-halal-cosmetics-market-trends-size-segment-and-growth-by-forecast-to-2030-3/
Europe Stevia Market – https://businessmarketins02.blogspot.com/2025/05/europe-stevia-market-trends-size.html
North America Functional Beverages Market – https://sites.google.com/view/businessmarketinsights233/home
North America Biodegradable Plastics Market – https://github.com/businessmarketinsights985/business-market-insights/issues/86
Europe Dental Market – https://www.linkedin.com/feed/update/urn:li:activity:7329122009718636569?utm_source=share&utm_medium=member_desktop&rcm=ACoAAFoU1YcBnRwRNJ26KRFoU-JXA3i-VZNmbCk
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Défense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author’s Bio
Akshay
Senior Market Research Expert at Business Market Insights
